通心络胶囊对不稳定性心绞痛患者C反应蛋白的影响  

Effect of Tongxinluo Capsule on C-reactive Protein in Patients with Unstable Angina

作　　者：巢为农[1] 万玉鸿[1] 刘亚平[2] 

机构地区：[1]江苏省常州市奔牛人民医院,江苏常州213131 [2]江苏省常州市第一人民医院,江苏常州213003

出　　处：《中国血液流变学杂志》2008年第3期357-358,共2页Chinese Journal of Hemorheology

摘　　要：目的探讨通心络胶囊对不稳定性心绞痛(UA)患者C反应蛋白(CRP)水平的影响。方法66例UA患者随机分为对照组(n=34)和通心络组(n=32),对照组予阿司匹林、氟伐他汀、美托洛尔或地尔硫卓口服8周,通心络组在上述治疗的基础上联合通心络胶囊,分别在治疗前、治疗2周、4周和8周后,应用速率散射比浊法测定血清CRP浓度。结果2组患者在治疗2周、4周和8周后,血清CRP浓度均明显低于治疗前(P<0.05,P<0.01,P<0.001),其中,在治疗4周和8周后,2组患者CRP浓度无差异,但在治疗2周后,通心络组明显低于对照组(P<0.05)。结论UA患者早期联合通心络胶囊有助于降低血清CRP水平,改善预后。Objective To study the effect of Tongxinluo capsule on C-reactive protein(CRP) in patients with unstable angina(UA).Methods 66 patients with UA were randomly divided into control group(n=34) and Tongxinluo group(n=32).Two groups were all treated with aspirin,fluvastatin and metoprolol or diltiazem for eight weeks,Tongxinluo group were combined with Tongxinluo capsule.The plasma levels of CRP were measured before and after treatment.Results CRP levels of two groups were all significantly lower than that befo...

关 键 词：心绞痛 不稳定性 C反应蛋白 通心络 

分 类 号：R259[医药卫生—中西医结合]